Corcept Therapeutics (CORT) Capital Expenditures Growth (3y) (2015 - 2025)
Corcept Therapeutics (CORT) Capital Expenditures Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.27% |
| Jun 30, 2025 | 44.22% |
| Mar 31, 2025 | 105.41% |
| Dec 31, 2024 | 23.01% |
| Sep 30, 2024 | 117.46% |
| Jun 30, 2024 | 51.77% |
| Sep 30, 2023 | -62.79% |
| Jun 30, 2023 | 29.47% |
| Dec 31, 2022 | -38.76% |
| Sep 30, 2022 | 7.06% |
| Jun 30, 2022 | -64.08% |
| Mar 31, 2022 | -63.99% |
| Dec 31, 2021 | -16.83% |
| Sep 30, 2021 | 52.31% |
| Jun 30, 2021 | 23.61% |
| Mar 31, 2021 | 17.84% |
| Dec 31, 2020 | 145.86% |
| Sep 30, 2020 | 106.11% |
| Jun 30, 2020 | -38.08% |
| Mar 31, 2020 | -27.45% |